Please login to the form below

Not currently logged in
From: Sales

Boehringer steals lead among NOACs with Pradaxa antidote

Has filed reversal agent for European approval

From: Research

NHSA awarded £2.9m to boost life and health sciences

Funding will support operations in the north of England for five years

From: Sales

German drug cost containment system 'aids data transparency'

New study by IQWiG suggests similar rules should be rolled out across Europe

From: Marketing

PMCPA 'appalled' by Chiesi's Code of Practice breach

pmcpa logoEthics watchdog says firm mislead it in a "completely unacceptable" manner

darwins medicine

Does 'trust leadership' feature in your strategy?

Pharma companies wanting to be more patient-focused will need to develop their people skills

2015: A year of promise and connectivity

How could technology impact healthcare in this year and what will be the key trends to follow?

FDA launches drug shortages mobile app

US regulator offers the public and HCPs Android and iPhone versions of the app

Takeda appoints Christophe Weber as its new CEO

Frenchman had been widely expected to succeed Yasuchika Hasegawa

Takeda pharma building

Transforming times at AstraZeneca

Lisa Anson, the company’s UK and Ireland president, on AZ's future direction

Mersana appoints Anna Protopapas as president and CEO

Joins from Millenium Pharmaceuticals

Sanofi joins WHO-backed diabetes mHealth programme

Becomes sole pharma partner for Be Healthy, Be Mobile's diabetes arm

mHealth mobile phone

Featured jobs

Subscribe to our email news alerts


Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
Russian innovation at the crossroads
Despite improvements, investors face rising risks...